Bionano Genomics, Inc. Share Price & Technical Analysis

BNGO · $1.22 (-1.61%)

Healthcare / Medical Instruments & Supplies

AI Score 29 · Bearish

$1.22

-1.61%

Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple

Price chart

Seasonality

May has 2 positive and 2 negative years (last 5 years shown)

0% return in May, 1% avg return in past 3 year May month.

-20% return in 2026, -162% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
26-13%-15%9%0%0%-20%
25-71%-18%-33%43%-5%-11%-9%27%-54%6%6%-21%-141%
24-37%6%-12%-23%9%-30%-9%-25%-8%-36%-13%4%-173%
2320%-26%-17%-38%-1%-13%-8%-36%-24%-54%12%16%-170%
22-27%-7%20%-37%7%-22%37%33%-25%26%-16%-30%-41%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 29/100

Bearish · Downtrend · Uptrend

Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It also provides Saphyr and Stratys systems, which are sample-to-result solutions for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr and Stratys instruments, which are single-molecule imagers; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA; and Ionic purification system, which isolates and purifies nucleic acid molecules. In addition, the company offers Saphyr, Stratys, and Bionano compute servers; and VIA software, which offers one solution for solutions for cytogenetics and molecular genetics. Further, it provides testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

$13.81M

P/E ratio

52W high

$5.50

52W low

$1.06

Volume

1,58,114

Beta

1.62

Related stocks in Healthcare

Frequently asked questions

What is Bionano Genomics, Inc. share price today?
Bionano Genomics, Inc. (BNGO) last traded around $1.22 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does BNGO have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for BNGO. Download the app for real-time alerts.
How can I analyze Bionano Genomics, Inc. stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro